Hospital Stocks Fall Today (Oct 12, 2026): Apollo Hospitals Slides on Supreme Court Drug-Pricing Hearing

Hospital stocks fall today after the Supreme Court asked the Centre a pointed question: why does its new cap on drug trade margins cover only cancer medicines? The selling came late, in the last hour of trade on Monday, October 12, 2026, and by the close Apollo Hospitals was the worst performer in the Nifty 50.

Hospital stocks fall today: the key moves

• Apollo Hospitals lost 3.2% to close at ₹7,775, the biggest Nifty 50 loser (Business Upturn).
• Max Healthcare ended 2% lower at ₹866.
• Fortis Healthcare slipped 3.5% and Aster DM Quality Care 2.8% during the session, Moneycontrol reported.
• Park Medi World was down as much as 6.5% at one point in the day.
• The BSE Hospitals index dropped 2.04%, making it the weakest BSE sector of the session (ET Now).

It was already a poor day for the wider market, and hospitals made it worse. ET Now had the Sensex down 547.65 points (0.76%) at 71,924.68 and the Nifty down 157.10 points (0.70%) at 22,363.35. CNBC-TV18 counted hospital stocks among the main reasons for the decline.

What the bench actually asked

The government’s position in court was that it has capped trade margins on anti-cancer drugs at 30% of the maximum retail price (MRP), as Bar and Bench reported. The cap is for non-scheduled cancer drugs, the ones that sit outside the regular price-control list.

Justices Vikram Nath and Sandeep Mehta weren’t convinced. They wanted to know why the cap ends at cancer drugs, and they pointed to mark-ups on very ordinary products:

• An Indian-made cardiac stent priced at ₹5,000 to the retailer, with an MRP of ₹25,000.
• Azithromycin carrying an MRP of ₹78.29 when the price to stockist is ₹28.50.

Additional Solicitor General Aishwarya Bhati pushed back. India, she argued, already has some of the cheapest medicines in the world, and too much intervention could hit availability. The next hearing is on October 27.

Why this worries hospital shareholders

This isn’t a fresh worry. Last month the court floated a uniform 16% margin on all medicines, according to Moneycontrol. Hospitals make a decent chunk of their income from the pharmacy and consumables patients buy, so a broad margin cap goes straight to profits.

The petition itself wants strict price controls on non-scheduled medicines and MRP caps on medical devices. The petitioner says the NPPA fixes ceiling prices for only about 1,000 “scheduled” drugs, leaving nearly 82% of medicines non-scheduled.

What it means for investors

The way we read it, the market has started pricing in regulatory risk that goes well beyond cancer drugs. Expect hospital stocks to jump at every court headline between now and October 27.

We’d keep an eye on two things:

• Whether the court pushes for margin caps on all medicines and devices.
• What hospital managements say about pharmacy margins in their Q2 results. Our guide on how to analyse quarterly results walks through what to check.

For the rest of Monday’s action, head to the Stock Market Today India hub and our piece on why the market is down today.

Sources: Moneycontrol, Bar and Bench, Business Upturn, ET Now and CNBC-TV18, all October 12, 2026. Prices are closing levels unless marked intraday.